If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Regulatory News (DVO)

  • There is currently no data for DVO

Trading Update

29 Apr 2015 07:00

RNS Number : 5817L
Devro PLC
29 April 2015
 



 29 April 2015

 

 

Devro plc

 

 

Trading Update

Devro plc, one of the world's leading manufacturers of collagen products for the food industry, issues the following trading update for the period from 1 January 2015 to date, ahead of its Annual General Meeting to be held at 11.00am today.

Trading has continued in line with the Board's expectations. Total sales volumes have now shown year on year growth for the fourth successive quarter, with strong performances in China, Japan, Germany and North America.

The major investment projects of building new plants in China and the USA continue to progress well, with both the schedule and the budget in line with previous guidance and production due to commence in 2016. The restructuring of Devro's operations in Scotland and Australia has now been completed as planned, and is on track to deliver the expected annual cost reductions of £5 million in 2015.

Operating cash flow continues to be strong, with net debt rising in line with expectations reflecting the planned investment programme.

Currency continues to be a headwind against prior year, but the Board remains confident in the outlook for 2015 which remains unchanged.

ENDS

 

 

For further information, please contact:

 

Devro plc

Peter Page, Chief Executive

Simon Webb, Group Finance Director

 

 

 

Tel No: 020 7182 4960

 

Buchanan

Charles Ryland / Robbie Ceiriog-Hughes

 

 

Tel No: 020 7466 5000

Notes to Editors

 

FTSE listed Devro (the "Group") is one of the world's leading providers of collagen casings to the food industry supplying a wide range of products and technical support to manufacturers of sausages, salamis, hams and other cooked meats. The Group employs 2,200 staff across the world and produces its casings from five manufacturing sites based in Scotland, Australia, the Czech Republic and the USA. Devro reported sales of £232.3 million and profit before tax (before exceptional items) of £26.1 million for the year ended 31 December 2014. Devro is a constituent of the FTSE4Good Index Series which recognises that the company's performance meets globally recognised corporate responsibility standards.

 Further information on Devro can be found on the company's website: www.devro.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEDFLAFISEIL
Date   Source Headline
20th Feb 202311:36 amRNSForm 8.3 - DEVRO PLC
20th Feb 202311:26 amRNSForm 8.3 - Devro Plc
20th Feb 202311:18 amRNSForm 8.5 (EPT/RI) - Devro plc
20th Feb 20239:43 amRNSForm 8.3 - Devro plc
17th Feb 20233:30 pmGNWForm 8.3 - Devro plc
17th Feb 20233:20 pmRNSForm 8.3 - Devro plc
17th Feb 20233:00 pmBUSForm 8.3 - DVO LN
17th Feb 20232:16 pmRNSForm 8.3 - DEVRO PLC
17th Feb 20231:34 pmEQSForm 8.3 - The Vanguard Group, Inc.: Devro plc
17th Feb 20231:30 pmBUSForm 8.3 - DEVRO PLC
17th Feb 202312:26 pmBUSForm 8.3 - Devro plc
17th Feb 202312:15 pmRNSForm 8.3 - Devro plc
17th Feb 202311:38 amRNSForm 8.3 - Devro Plc
17th Feb 202311:13 amRNSForm 8.3 - Devro plc
17th Feb 202310:48 amRNSForm 8.5 (EPT/NON-RI) - Devro plc
17th Feb 202310:44 amRNSForm 8.5 (EPT/NON-RI) - Devro plc
17th Feb 202310:37 amRNSForm 8.5 (EPT/RI) - Devro plc
17th Feb 202310:09 amRNSForm 8.5 (EPT/RI) - Devro PLC
16th Feb 20231:16 pmRNSForm 8.5 (EPT/RI) - Devro plc Amend
16th Feb 202312:30 pmRNSForm 8.3 - DEVRO PLC
16th Feb 202311:51 amRNSCourt & General Meetings adjourned
16th Feb 202310:34 amRNSForm 8.5 (EPT/NON-RI) - Devro plc
16th Feb 202310:26 amRNSForm 8.5 (EPT/RI) - Devro plc
16th Feb 20239:30 amRNSIncreased and Final Recommended Cash Acquisition
15th Feb 20232:23 pmRNSForm 8.3 - DEVRO PLC
15th Feb 202310:54 amBUSForm 8.3 - Devro plc
15th Feb 202310:16 amRNSForm 8.5 (EPT/RI)-Devro plc
15th Feb 202310:11 amRNSForm 8.3 - Devro Plc
14th Feb 20234:13 pmRNSForm 8.3 - Devro Plc
14th Feb 20233:42 pmRNSForm 8.5 (EPT/RI)-Devro plc Amend
14th Feb 20233:41 pmRNSForm 8.5 (EPT/RI)-Devro plc Amend
14th Feb 202310:09 amRNSForm 8.5 (EPT/RI) - Devro plc
14th Feb 202310:05 amBUSForm 8.3 - Devro plc
13th Feb 20232:34 pmEQSForm 8.3 - The Vanguard Group, Inc.: Devro plc
13th Feb 202311:43 amRNSForm 8.3 - DEVRO PLC
13th Feb 202310:57 amGNWForm 8.3 - [Devro plc - 10 02 2023] - (CGWL)
13th Feb 202310:39 amRNSForm 8.5 (EPT/RI)-Devro plc
10th Feb 20231:56 pmRNSForm 8.3 - DEVRO PLC
10th Feb 202312:56 pmEQSForm 8.3 - The Vanguard Group, Inc.: Devro plc
10th Feb 202310:13 amRNSForm 8.5 (EPT/RI) - Devro PLC
10th Feb 202310:09 amRNSForm 8.5 (EPT/RI) - Devro plc
9th Feb 20234:28 pmRNSForm 8.5 (EPT/RI) - Devro plc Amend
9th Feb 20234:26 pmRNSForm 8.5 (EPT/RI) - Devro plc Amend
9th Feb 202312:39 pmRNSForm 8.3 - DEVRO PLC
9th Feb 202312:27 pmGNWForm 8.3 - [Devro plc - 08 02 2023] - (CGWL)
9th Feb 202311:41 amRNSForm 8.3 - Devro Plc
9th Feb 202311:30 amRNSForm 8.3 - Devro plc
9th Feb 202310:45 amRNSForm 8.5 (EPT/RI) - Devro plc
9th Feb 202310:20 amRNSForm 8.5 (EPT/RI) - Devro PLC
8th Feb 20232:35 pmRNSForm 8.3 - DEVRO PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.